Center for Translational and Public Health Genomics
The Center for Translational and Public Health Genomics (CTPHG) was created to bridge the gap between epidemiologic discoveries and their translation into clinical and public health applications to benefit cancer patients, individuals at elevated risk for cancer, and the general population. Leveraging the large patient population and healthy controls with comprehensive data and biospecimens and the rapid development of new high-throughput biomedical technologies that generate genomic information at an unprecedented pace, the Center contributes to the institutional commitment of personalized medicine by providing expertise in translational genomics for cancer risk, prevention interventions, progression from pre-malignancy to cancer, pharmacogenomics to predict therapeutic response, and survivorship and quality of life. More information
Mentored Junior Faculty Fellowship
Applications are being accepted for the Duncan Family Institute Mentored Junior Faculty Fellowship in Cancer Prevention Research.
Read more.
Institute Faculty in the News
- Are women meeting cancer-prevention recommendations? Not really Jennifer Irvin Vidrine, Ph.D.
- Houston study examines one race for links between obesity, proximity to fast Lorraine Reitzel, Ph.D.
- Angelina Jolie's news: Docs talk about breast cancer Powel Brown, M.D., Ph.D.
- Smoking and tobacco-cessation campaign to be launched by Texas and Mexico institutions Ernest Hawk, M.D., M.P.H.